At Prescient, we’ve managed pharmaceutical product launches across primary care, oncology, rare disease, and everything in between. And whether we’re championing a first-in-class innovation or a late entrant in a competitive space, one thing is certain: how you launch matters just as much as what you launch.
We’ve seen promising products miss the mark because the initial groundwork didn’t set them up for success. We’ve also witnessed brands exceed expectations because their teams approached launch as a capability, rather than a one-off event.
The companies that constantly lead the field take a long-term view. They prepare early, compile solid evidence, align internal teams, design for the patient experience, and stay ready to adapt as new challenges and opportunities emerge. That’s what pharma launch excellence looks like in action, and it continues to be a critical success factor for any pharmaceutical product launch today.
What the data tells us: Insights from Uptake’s (Part of Prescient) LExLevel Pulse Report
To better understand how pharma teams are advancing across the industry, Uptake (part of Prescient) developed a first-of-its-kind benchmarking tool that evaluates launch competencies across seven key levers. Based on self-assessments from global, regional, and country-level professionals, the report highlights both strengths and gaps in current launch practices.
The findings show that while many organisations have foundational structures in place, few rate themselves as truly exceptional across all areas. This presents significant potential for teams to commit to the core enablers that deliver sustained value.
Characteristics of breakthrough pharma product launches
Superior pharmaceutical product launches are rooted in clarity, foresight, and the ability to act decisively. Best-in-class teams stay grounded in the essentials while remaining agile enough to evolve with the data, the landscape, and the needs of their stakeholders.
1 – Market leaders prioritise evidence, not just approval
In high-performing teams, the value story is set in motion well before regulatory sign-off. Top teams generate compelling real-world evidence (RWE) pre- and post-launch to demonstrate how their product translates into clinical practice, beyond the confines of controlled trial environments.
From pricing and market access negotiations to field force messaging, robust evidence gives you the power to own the narrative, instead of following it.
According to our report data, only 12% of pharma teams rated their launch resourcing as ‘Exceptional,’ highlighting a major opportunity to invest earlier and more strategically in evidence generation and team capabilities.
2 – They put patients at the centre, by design
A common trait across the most convincing pharmaceutical product launches is a deep focus on the patient journey. This goes beyond lip service. We’re talking about onboarding tools, digital support platforms, nurse coaching, affordability programmes, designed from Day 0.
True pharma launch excellence embodies a complete solution, one that facilitates adherence, improves outcomes, and bolsters reputation with healthcare systems.
3 – They enable cross-functional alignment that sticks
Great pharmaceutical product launches don’t happen in silos. Medical, commercial, market access, digital, and field teams all need to work cohesively and pull in the same direction. That alignment must be both strategic and operational, with distinct roles, KPIs, and shared accountability.
At Uptake (part of Prescient), we’ve crafted cross-functional launch playbooks and simulation programmes that let teams plan collaboratively and respond quickly in real time.
While 82% of organisations report having governance frameworks in place, many still struggle to apply them consistently, especially around readiness reviews and post-launch optimisation, according to our research.
4 – They concentrate on capability, not just performance
Elite organisations treat launch excellence as a discipline, transforming success from a one-off into a repeatable habit. Achievement comes not only from high-impact brand leadership, but from clearly defining what good looks like and weaving it into execution models across teams.
We’ve partnered with clients to roll out global Launch Excellence Toolkits, embed training modules, and establish Centres of Excellence to equip country teams, accelerating ramp-up, enhancing confidence, and delivering results that scale.
5 – They harness digital to personalise and optimise
Digital plays a central role in launch precision. The most esteemed teams use data-driven segmentation, smart content orchestration, and digital-first engagement strategies to provide tailored messages to the right stakeholders at the right time.
Digital maturity now directly influences launch effectiveness. Falling behind in this area poses a strategic risk for your brand.
6 – They adapt continuously, not post-mortem
Standout teams routinely monitor uptake, feedback, and competitor activity, allowing them to make timely adjustments before issues escalate. This agility means they can course-correct early, without relying solely on post-launch reviews.
We’ve guided clients through the setup of live dashboards, conducted weekly pulse reviews, and implemented rapid ‘plan-do-check-adjust’ loops to stay ahead of market dynamics.
Nearly half (47%) of pharma teams are at a foundational level in scenario planning, leaving them exposed to sudden market shifts and competitor activity, as revealed in our report findings.
Launch excellence sets the pace
In today’s setting, where payers are cautious, competitors aggressive, and patients increasingly empowered, pharma launch excellence has become integral to longstanding commercial and clinical viability.
At Uptake (part of Prescient), we believe every pharmaceutical product launch is a chance to build lasting momentum for the brand as well as the organisation. With the right strategy, expertise, and mindset, launch can serve as a springboard for brand and organisational growth.
Curious how your launch approach compares? Download the full LExLevel Pulse Report to discover how your team benchmarks across our seven key levers, and where the biggest opportunities lie.
We’ve seen what great looks like. And we’d love to help you get there.
The Uptake Launch Excellence Report 2026
